Skip to content

Italian Medicines Agency Adopts Template Setting Out Minimum Content Of Commercial Clinical Trial Agreements

Nicola Landolfi

DOI https://doi.org/10.21552/eplr/2020/2/9



Nicola Landolfi is an Associate at DLA Piper (Rome). The views expressed in this publication are those of the author and do not represent the views of the firm or any third party. For correspondence: <mailto:nicola.landolfi@dlapiper.com>.

Share


Lx-Number Search

A
|
(e.g. A | 000123 | 01)

Export Citation